Limiting dilution assay for human B cells based on their activation by mutant EL4 thymoma cells: total and antimalaria responder B cell frequencies.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMID 3297736)

Published in Eur J Immunol on June 01, 1987

Authors

L Wen, M Hanvanich, C Werner-Favre, N Brouwers, L H Perrin, R H Zubler

Articles citing this

Clonal dissection of the human memory B-cell repertoire following infection and vaccination. Eur J Immunol (2009) 1.74

Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem. Front Immunol (2012) 1.50

Are cord blood B cells functionally mature? Clin Exp Immunol (1991) 1.05

Anti-malaria antibody-producing B cell frequencies in adults after a Plasmodium falciparum outbreak in Madagascar. Clin Exp Immunol (1995) 1.01

Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor alpha, interleukin (IL)6, IL-10, and transforming growth factor beta 1 mRNAs. J Exp Med (1993) 1.00

CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells. Immunology (1993) 0.94

Mining human antibody repertoires. MAbs (2010) 0.92

The B cell repertoire of patients with rheumatoid arthritis. Frequencies and specificities of peripheral blood B cells reacting with human IgG, human collagens, a mycobacterial heat shock protein and other antigens. Clin Exp Immunol (1993) 0.88

Accessing the human repertoire for broadly neutralizing HIV antibodies. MAbs (2011) 0.88

Quantification of antibody-secreting lymphocytes that react with Pf155/RESA from Plasmodium falciparum: an ELISPOT assay for field studies. Clin Exp Immunol (1993) 0.85

Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals. Clin Exp Immunol (2001) 0.80

HybriFree: a robust and rapid method for the development of monoclonal antibodies from different host species. BMC Biotechnol (2016) 0.78

Frequencies of HIV-reactive B cells in seropositive and seronegative individuals. Clin Exp Immunol (1992) 0.78

Precursor frequencies for DNA-specific B lymphocytes in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1994) 0.78

Signals sustaining human immunoglobulin V gene hypermutation in isolated germinal centre B cells. Immunology (2000) 0.78

Epstein-Barr virus transformation of Saimiri sciureus (squirrel monkey) B cells and generation of a Plasmodium brasilianum-specific monoclonal antibody in P. brasilianum-infected monkeys. Infect Immun (1991) 0.77

Clonal diversification in OspA-specific antibodies from peripheral circulation of a chronic Lyme arthritis patient. J Immunol Methods (2007) 0.76

Human B lymphocytes mature. Clin Exp Immunol (1991) 0.75

Articles by these authors

Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus. J Immunol (1976) 9.28

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med (1999) 6.27

Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease. J Clin Invest (1976) 5.96

Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med (1999) 3.45

The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature (2001) 3.45

Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell (2001) 3.44

Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. J Clin Invest (1975) 2.97

Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. J Exp Med (1984) 2.74

Hemispherical variations in seismic velocity at the top of the Earth's inner core. Nature (2001) 2.67

Surgical complications secondary to decompressive craniectomy in patients with a head injury: a series of 108 consecutive cases. Acta Neurochir (Wien) (2008) 2.59

Immunity to asexual erythrocytic stages of Plasmodium falciparum: role of defined antigens in the humoral response. Immunol Rev (1982) 2.49

CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med (1996) 2.42

APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31

Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages. J Exp Med (1984) 2.16

Inhibition of P. falciparum growth in human erythrocytes by monoclonal antibodies. Nature (1981) 2.05

Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity. J Clin Invest (1977) 1.97

T-cell alpha beta + and gamma delta + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium. Proc Natl Acad Sci U S A (1996) 1.92

Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes. Nature (1985) 1.90

Inhibition of T cell-mediated functions by MVM(i), a parvovirus closely related to minute virus of mice. J Immunol (1981) 1.87

Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature (1985) 1.85

Protein kinase C-stimulated phosphorylation in vitro of a Mr 80,000 protein phosphorylated in response to phorbol esters and growth factors in intact fibroblasts. Distinction from protein kinase C and prominence in brain. J Biol Chem (1986) 1.84

Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis (1998) 1.72

Immune complexes and complement hypercatabolism in patients with leprosy. Clin Exp Immunol (1976) 1.66

High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood (2000) 1.63

Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway. J Exp Med (1976) 1.57

Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology (2008) 1.56

Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme. AIDS (1992) 1.55

Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction. J Immunol (1985) 1.53

Contralateral subdural effusion secondary to decompressive craniectomy performed in patients with severe traumatic brain injury: incidence, clinical presentations, treatment and outcome. Med Princ Pract (2008) 1.53

Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases. Clin Infect Dis (1993) 1.52

Immunization with a Plasmodium falciparum merozoite surface antigen induces a partial immunity in monkeys. J Clin Invest (1985) 1.43

A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia. Aust N Z J Med (2000) 1.42

An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42

Murine lupus in the absence of alpha beta T cells. J Immunol (1996) 1.41

The in vitro generation and functional analysis of murine T cell populations and clones specific for a protozoan parasite, Leishmania tropica. Immunol Rev (1982) 1.40

Opsonic activity of human immune serum on in vitro phagocytosis of Plasmodium falciparum infected red blood cells by monocytes. Clin Exp Immunol (1982) 1.39

Detection of immune complexes in human diseases. Prog Allergy (1978) 1.35

Requirement for three signals in "T-independent" (lipopolysaccharide-induced) as well as in T-dependent B cell responses. J Exp Med (1982) 1.35

Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J Immunol (1988) 1.33

Circulating and tissue-bound immune complex formation in murine malaria. J Immunol (1979) 1.32

A single morphogenetic field gives rise to two retina primordia under the influence of the prechordal plate. Development (1997) 1.32

Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies. Proc Natl Acad Sci U S A (1986) 1.32

Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3. J Immunol (1997) 1.31

Quantitation of C3PA (properdin factor B) and other complement components in diseases associated with a low C3 level. Clin Immunol Immunopathol (1973) 1.28

Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes. J Immunol (1977) 1.27

Phagocytosis of Plasmodium falciparum-parasitized erythrocytes by human polymorphonuclear leukocytes. J Parasitol (1983) 1.26

Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration. Clin Exp Immunol (2000) 1.25

The N-terminal leucine-rich regions in Slit are sufficient to repel olfactory bulb axons and subventricular zone neurons. J Neurosci (2001) 1.24

Cloning and expression in Escherichia coli of a surface antigen of Plasmodium falciparum merozoites. EMBO J (1985) 1.20

Lymphocyte proliferation in mice congenitally deficient in T-cell receptor alpha beta + cells. Proc Natl Acad Sci U S A (1994) 1.20

Requirement for three signals in B cell responses. II. Analysis of antigen- and Ia-restricted T helper cell-B cell interaction. J Exp Med (1982) 1.19

Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes. J Exp Med (1977) 1.18

Characterization of antigens from erythrocytic stages of Plasmodium falciparum reacting with human immune sera. Trans R Soc Trop Med Hyg (1981) 1.17

Aldolase activity of a Plasmodium falciparum protein with protective properties. Science (1988) 1.17

Immunization against Plasmodium falciparum asexual blood stages using soluble antigens. Clin Exp Immunol (1984) 1.16

Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(-)CD14(-) and a CD34(-)CD14(+) dendritic cell precursor. Blood (1999) 1.15

Purification and characterization of adult diarrhea rotavirus: identification of viral structural proteins. J Virol (1989) 1.15

Suppression of p53 activity by Siva1. Cell Death Differ (2009) 1.14

Decreased capacity to solubilize immune complexes in sera from patients with systemic lupus erythematosus. Arthritis Rheum (1981) 1.14

Validity of the three-column theory of thoracolumbar fractures. A biomechanic investigation. Spine (Phila Pa 1976) (1995) 1.12

Cell surface antigen CD5 is a marker for activated human B cells. Eur J Immunol (1989) 1.12

Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters. J Infect Dis (1992) 1.11

Alzheimer dementia caused by a novel mutation located in the APP C-terminal intracytosolic fragment. Hum Mutat (2006) 1.10

Properdin levels in systemic lupus erythematosus and membranoproleferative glomerulonephritis. Clin Exp Immunol (1974) 1.10

Improved enzyme immunoassays for the detection of antigens in fecal specimens. Investigation and correction of interfering factors. J Immunol Methods (1984) 1.10

The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells. J Immunol (1986) 1.09

Transcription repression by Xenopus ET and its human ortholog TBX3, a gene involved in ulnar-mammary syndrome. Proc Natl Acad Sci U S A (1999) 1.09

Investigation of an outbreak of adult diarrhea rotavirus in China. J Infect Dis (1989) 1.08

Omi/HtrA2 is a positive regulator of autophagy that facilitates the degradation of mutant proteins involved in neurodegenerative diseases. Cell Death Differ (2010) 1.07

Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody. J Exp Med (1979) 1.07

Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patients. Magn Reson Imaging (2000) 1.06

Lysis of human cultured lymphoblastoid cells by cell-induced activation of the properdin pathway. Science (1977) 1.06

Gamma delta T cell help of B cells is induced by repeated parasitic infection, in the absence of other T cells. Curr Biol (1996) 1.05

The expression in vivo of a second isoform of pT alpha: implications for the mechanism of pT alpha action. J Immunol (1998) 1.05

Are cord blood B cells functionally mature? Clin Exp Immunol (1991) 1.05

Correlation between levels of breakdown products of C3, C4, and properdin factor B in synovial fluids from patients with rheumatoid arthritis. Arthritis Rheum (1977) 1.04

Theoretical and practical aspects of B-cell activation: murine and human systems. Immunol Rev (1987) 1.04

Detection and quantitation in plasma and synovial fluid of a fragment of human C4 with alpha mobility generated during the activation of the complement system. J Immunol (1975) 1.04

The hematology of malaria in man. Semin Hematol (1982) 1.03

Stool desorbing activity: a possible cause of false-positive reactions in competitive enzyme immunoassays. J Clin Microbiol (1985) 1.02

Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid. Rheumatology (1975) 1.01

Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes. J Exp Med (1976) 1.01

Plasmodium falciparum: characterization of defined antigens by monoclonal antibodies. Clin Exp Immunol (1980) 1.00

Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor alpha, interleukin (IL)6, IL-10, and transforming growth factor beta 1 mRNAs. J Exp Med (1993) 1.00

Feedback suppression of the immune response in vitro. II. IgVH-restricted antibody-dependent suppression. J Exp Med (1980) 0.99

Immune complexes and complement catabolism in ankylosing spondylitis. Arthritis Rheum (1977) 0.99

Feedback suppression of the immune response in vitro. I. Activity of antigen-stimulated B cells. J Exp Med (1980) 0.99

Alphamethrin-impregnated bed nets for malaria and mosquito control in China. Trans R Soc Trop Med Hyg (1995) 0.99

Glomerulonephritis associated with hepatitis B. report of a case and review of the literature. Clin Nephrol (1977) 0.99

B23 acts as a nucleolar stress sensor and promotes cell survival through its dynamic interaction with hnRNPU and hnRNPA1. Oncogene (2010) 0.99

Novel PRRT2 mutations in paroxysmal dyskinesia patients with variant inheritance and phenotypes. Genes Brain Behav (2012) 0.98

Giant enhancement of hydrogen transport in rutile TiO2 at low temperatures. Phys Rev Lett (2010) 0.97

The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice. J Exp Med (1998) 0.96

Expression, purification, biochemical characterization and inhibition of recombinant Plasmodium falciparum aldolase. Mol Biochem Parasitol (1990) 0.96